Medtronic Achieves CE Mark for BrainSense Adaptive Deep Brain Stimulation
Medtronic has received CE Mark approval for its BrainSense technology, an innovative adaptive deep brain stimulation (aDBS) system that offers personalised treatment for neurological disorders such as Parkinson’s disease.
Unlike traditional DBS, BrainSense continuously monitors brain activity and automatically adjusts stimulation levels in real time based on the patient’s needs. This adaptive approach enhances symptom management and improves patient outcomes. Additionally, Medtronic has introduced the Percept PC Electrode Identification System, designed to assist healthcare professionals in accurately identifying implanted electrodes.
This CE Mark approval further solidifies Medtronic’s position as a leader in cutting-edge neurotechnology, providing more precise, patient-centric care for those with movement disorders.
For more details, read the full article on Med-Tech News: Medtronic Achieves CE Mark for BrainSense Adaptive Deep Brain Stimulation
Credit for images and content: Med-Tech News & Medtronic
____________________________________________________________________________________________________________________________________________________________________________________________________
Cure Talent is a recruitment agency dedicated to the medical technology industry. Whether you are looking for a new role in the medical device sector or you’re an innovative medical device, digital health, or biotech company looking for staff, get in touch with the team today and explore how Cure Talent can help!